Shirai M - Search Results

1

Multiple pathways are involved in the extracellular processing of MHC class I-restricted peptides.

Kozlowski S, Corr M, Shirai M, Boyd LF, Pendleton CD, Berzofsky JA, Margulies DH. Kozlowski S, et al. Among authors: shirai m. J Immunol. 1993 Oct 15;151(8):4033-44. J Immunol. 1993. PMID: 8409383

2

Broad recognition of cytotoxic T cell epitopes from the HIV-1 envelope protein with multiple class I histocompatibility molecules.

Shirai M, Pendleton CD, Berzofsky JA. Shirai M, et al. J Immunol. 1992 Mar 15;148(6):1657-67. J Immunol. 1992. PMID: 1371784

3

Preferential V beta usage by cytotoxic T cells cross-reactive between two epitopes of HIV-1 gp160 and degenerate in class I MHC restriction.

Shirai M, Vacchio MS, Hodes RJ, Berzofsky JA. Shirai M, et al. J Immunol. 1993 Aug 15;151(4):2283-95. J Immunol. 1993. PMID: 7688397

4

Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs.

Shirai M, Pendleton CD, Ahlers J, Takeshita T, Newman M, Berzofsky JA. Shirai M, et al. J Immunol. 1994 Jan 15;152(2):549-56. J Immunol. 1994. PMID: 8283036

5

Reciprocal cytotoxic T lymphocyte cross-reactivity interactions between two major epitopes within HIV-1 gp160.

Shirai M, Kurokohchi K, Pendleton CD, Arichi T, Boyd LF, Takahashi H, Margulies DH, Berzofsky JA. Shirai M, et al. J Immunol. 1996 Nov 15;157(10):4399-411. J Immunol. 1996. PMID: 8906815

6

Degenerate MHC restriction reveals the contribution of class I MHC molecules in determining the fine specificity of CTL recognition of an immunodominant determinant of HIV-1 gp160 V3 loop.

Shirai M, Kozlowski S, Margulies DH, Berzofsky JA. Shirai M, et al. J Immunol. 1997 Apr 1;158(7):3181-8. J Immunol. 1997. PMID: 9120272

7

Induction of cytotoxic T cells to a cross-reactive epitope in the hepatitis C virus nonstructural RNA polymerase-like protein.

Shirai M, Akatsuka T, Pendleton CD, Houghten R, Wychowski C, Mihalik K, Feinstone S, Berzofsky JA. Shirai M, et al. J Virol. 1992 Jul;66(7):4098-106. doi: 10.1128/JVI.66.7.4098-4106.1992. J Virol. 1992. PMID: 1376366 Free PMC article.

8

CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1.

Shirai M, Arichi T, Nishioka M, Nomura T, Ikeda K, Kawanishi K, Engelhard VH, Feinstone SM, Berzofsky JA. Shirai M, et al. J Immunol. 1995 Mar 15;154(6):2733-42. J Immunol. 1995. PMID: 7533182

9

Helminth infection results in decreased virus-specific CD8+ cytotoxic T-cell and Th1 cytokine responses as well as delayed virus clearance.

Actor JK, Shirai M, Kullberg MC, Buller RM, Sher A, Berzofsky JA. Actor JK, et al. Among authors: shirai m. Proc Natl Acad Sci U S A. 1993 Feb 1;90(3):948-52. doi: 10.1073/pnas.90.3.948. Proc Natl Acad Sci U S A. 1993. PMID: 8094248 Free PMC article.

10

T cell recognition of hypervariable region-1 from hepatitis C virus envelope protein with multiple class II MHC molecules in mice and humans: preferential help for induction of antibodies to the hypervariable region.

Shirai M, Arichi T, Chen M, Masaki T, Nishioka M, Ikeda K, Takahashi H, Enomoto N, Saito T, Major ME, Nakazawa T, Akatsuka T, Feinstone SM, Berzofsky JA. Shirai M, et al. J Immunol. 1999 Jan 1;162(1):568-76. J Immunol. 1999. PMID: 9886434

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

956 results

Search Page

Filters